COPD: new developments and therapeutic opportunities. 14-16 June 1999, National Heart & Lung Institute, London, UK.
This meeting was organized by Professors Peter Barnes (National Heart & Lung Institute, London, UK) and Neil Pride (National Heart and Lung Institute, London, UK) to highlight the major health problems caused by chronic obstructive pulmonary disease (COPD). It also addressed the efficacy of existing therapeutic approaches as well as examining progress in developing novel classes of therapeutic agents and in improving our understanding of the disease. This well organized meeting was attended by approximately 100 delegates, the majority of whom were chest physicians, with a significant number of delegates from the pharmaceutical industry. In turn, the sessions addressed the definition and pathophysiology of the disease, the development of methodology suitable for performing clinical studies and then various therapeutic approaches culminating with lectures describing the potential of phosphodiesterase (PDE) 4 inhibitors.